Kipp H.

Kipp H. has extensive experience in the field of quality assurance and regulatory affairs. Kipp currently works as the Associate Director of GCP/GLP Quality Assurance at Sio Gene Therapies since March 2021. Prior to that, they served as the Associate Director of Quality Assurance at PRA Health Sciences from May 2017 to March 2021. Kipp also held the role of Director of Quality and Regulatory Affairs at Aplion Medical Corp from August 2015 to May 2017.

In previous positions, Kipp served as the Quality Manager at Integra LifeSciences from August 2013 to July 2015, where they managed various quality systems and processes. Before that, they worked as the QMS Manager at GE Healthcare from September 2011 to August 2013. Kipp also held the position of Director of Quality Assurance at NanoString Technologies from August 2009 to June 2011, where they were responsible for implementing ISO 13485 standards and ensuring compliance with 21 CFR Part 820.

Earlier in their career, Kipp served as the Director of QA at Targeted Genetics from April 2004 to July 2009, overseeing all quality functions for the company. Prior to that, they worked as the Senior Manager of QA at Cephalon and as the QA Manager at Anesta Corp.

Throughout their career, Kipp has demonstrated expertise in quality management, regulatory compliance, validation, and audit processes.

Kipp H. attended the University of Utah from 1990 to 1993, where they received a Bachelor of Science degree. Kipp'smajor was Biology, with a minor in Chemistry.